Together, these findings support that Bacteroides fragilis abundant in AD patient gut microbiomes may activate C/EBPβ/AEP pathway and stimulate microglia activation via PGE2 and 12-HHTrE, two major metabolites from PUFA by these bacteria. Here, CEBPB is linked to Alzheimer disease.